Charles (Chuck) C. Carnevale is the creator of FAST Graphs.
Chuck has over 43 years of financial experience and is the co-founder of the earnings and price correlated, powerful fundamentals analyzer software tool - FAST Graphs. Chuck holds a Bachelor of Science in Economics and Finance from the University of Tampa. Chuck's work stressing sound valuation has been widely published on numerous financial sites and blogs. Chuck is passionate about spreading the critical message of valuation and prudence in fundamental investing. So much so that regular readers have dubbed him "Mr. Valuation". Chuck is a Veteran of the Vietnam War and was awarded both the Bronze Star and the Vietnam Honor Medal.
Chuck believes that correctly assessing fair value is one of the primary keys of successful stock investing, and he has dedicated his more than 40 years of experience in finance to its pursuit. Chuck agrees with legendary investors such as Warren Buffett, who recognize how important it is for investors in common stocks to possess an intelligent framework for making sound decisions that can keep emotions out of the equation. With making smart stock selections, there is no room for fear and greed.
Chuck was fortunate to learn at an early age that earnings drive long-term stock prices, and that dividends, if any, will be paid out of a company's earnings. This led him to develop FAST Graphs, the fundamentals analyzer software tool that reveals the long-term relationship between a company's earnings and its stock price and dividends over time. Chuck is most interested in the business behind the stock.
Recent Articles By The Author
Aaron's Rents, You Should Own the Stock
During these uncertain economic times, there is ample room for Aaron's to grow.
A Bizarro Market Reaction to Oracle
Oracle's growth is far from over. So why is the market reacting so negatively to a 1-cent earnings miss?
Carnevale: Is AmSurg a Perfect Obamacare Growth Stock?
AmSurg is currently trading at a sound valuation, which makes it particularly appealing in the age of Obamacare.
Carnevale: Cramer Likes CVS Caremark -- And So Do I
The drug retailer's growth is strong, and its stock is at an attractive level.
Carnevale: Ross Stores a Buy on Bad News (Update 1)
It is completely irrational to believe that the intrinsic value of a publicly-traded company like Ross Stores could change by as much as 7% in one day.
Carnevale: Microsoft Too Cheap to Ignore
It's time to change how we look at this blue-chip, high-yielding dividend growth stock.